Evelo Biosciences, Inc. announced that on May 31, 2022, Luca Scavo delivered his resignation as the Chief Financial Officer of the Company, effective June 3, 2022, to pursue another professional opportunity. The Company will conduct a search for Mr. Scavo's replacement and, pending the appointment of such replacement, intends to designate Balkrishan Simba Gill, Ph.D., the Chief Executive Officer and President of the Company, as the Company's principal financial officer ad interim.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0457 USD | +3.39% | -8.60% | -25.69% |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
1st Jan change | Capi. | |
---|---|---|
-25.69% | 868K | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.73% | 22.02B | |
-17.84% | 20.9B | |
-9.05% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- EVLO Stock
- News Evelo Biosciences, Inc.
- Evelo Biosciences, Inc. Announces Executive Changes